Global Immunohistochemistry Market Is Estimated To Witness Significant Growth Owing To Rising Prevalence Of Chronic Diseases And Rising Point-Of-Care Diagnostics

Immunohistochemistry Market
Immunohistochemistry Market

Overview:

Immunohistochemistry is a powerful technique used in clinical diagnostics to detect specific antigens in tissue sections with the help of antibodies. It also plays an essential role in basic research aimed at understanding the distribution and localization of biomarkers and differentially expressed proteins in biological tissue.

IHC is performed on paraffin-embedded tissue (PET) or formalin fixed paraffin embedded tissue (FFPE). It is widely used to determine cell type and organ of origin in anatomic pathology, as well as detecting specific biomarkers and predictive and prognostic biomarkers for malignancies and cancer therapy. Various detection methods are utilized for IHC, with the most common being immunofluorescence (IF) and chromogenic IHC.

Market Dynamics:

Increasing product launches are estimated to augment growth of the global Immunohistochemistry Market during the forecast period. For instance, the Anti-PRAME (EPR 20330) Rabbit Monoclonal Primary Antibody was launched by Roche in September 2022. It is used for identifying PRAME protein expression in samples from patients that were suspected of melanoma. Moreover, rising cost and high degree of consolidation are anticipated to restrain growth of the global immunohistochemistry for market during the forecast period.

Impact of COVID-19:

COVID-19 had an adverse impact on many sectors like automobile, electronics, aerospace and many more. However, it had the most significant impact on the healthcare sector. The number of patients were increasing daily and this put immense pressure on the healthcare sector.

As the number of patients were increasing there was a shortage of drugs, medical supplies and skilled professionals. Large number of people were being tested on a daily basis for the disease and this led to increasing demand for immunohistochemistry. Thus, the pandemic had a positive impact on the growth of the global immunohistochemistry for market.

Key Takeaways:

The global Immunohistochemistry Market is expected to witness robust growth, exhibiting CAGR of 6.6 % over the forecast period, due to growing product approvals.

For instance, VENTANA MMR RxDx Panel from Roche was approved by the US FDA in August 2021. It is used for identifying dMMR solid tumor patients that were eligible for anti-PD-1 immunotherapy.

North America is anticipated to witness robust growth in the global immunohistochemistry for market during the forecast period, due to growing presence of key players and rising availability of IHC solutions.

Key players active in the global Immunohistochemistry Market are Thermo Fisher Scientific Inc., Abcam plc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Merck KGaA, Bio SB, Danaher Corporation, Cell Signaling Technology, Inc., Perkinelmer, Inc., and Bio-Rad Laboratories, Inc.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more